Cutaneous ureterostomy in adults.
In the patient with metastatic carcinoma, urinary diversion is usually achieved with indwelling ureteral stents or placement of a percutaneous nephrostomy tube. Most forms of surgical diversion carry an unacceptable morbidity rate, especially in the debilitated patient. Over a fifteen-year period (1974-1989), 29 adult patients with pelvic malignancy (32 ureters) underwent palliative cutaneous ureterostomy. This previously reported technique involves transverse nephropexy and construction of a stoma using a small skin flap. Indications included ureteral obstruction or severe urinary tract symptoms. Hydroureter, often considered a precondition for this procedure, was not present in several patients and was not a prerequisite to success. Complications related to the procedure included one postoperative death due to stroke, one death due to uremia and sepsis, and one instance of severe renal arterial stenosis resulting in renal failure. Preservation of renal function was possible in the 10 patients known to have survived from one to thirteen years postoperatively; only 3 patients eventually required stomal revision. By adherence to the surgical techniques described, the usually high incidence of stomal stenosis was avoided. Our experience reveals that although the indications for cutaneous ureterostomy are limited, this procedure can provide an alternative to permanent nephrostomy drainage or to a higher risk intestinal urinary diversion in carefully selected patients with a reasonable life expectancy.
Kearney
G P
GP
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Docimo
S G
SG
Doyle
C J
CJ
Mahoney
E M
EM
D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010166:Palliative Care / Q000379:methods*; D011183:Postoperative Complications / Q000453:epidemiology; D012307:Risk Factors; D015607:Stents; D014517:Ureteral Obstruction / Q000209:etiology / Q000601:surgery*; D014519:Ureterostomy / Q000379:methods*; D001749:Urinary Bladder Neoplasms / Q000150:complications; D002583:Uterine Cervical Neoplasms / Q000150:complications